Subscribe to Newsletter

Cold Medicine API Screen Using a Kinetex® EVO C18 Core-Shell LC Column


The current range of compounds aimed at the treatment of the common cold is quite large and comprises ingredients of a variety of chemical characteristics. This is the direct result of a diverse array of pharmaceutical formulations that contain more than one active ingredient and target multiple symptoms at once. With such a mixture of polar compounds, resolution, sensitivity, and speed are all important parameters. Using a high performance core-shell Kinetex 2.6 μm EVO C18 column we achieve comprehensive resolution, narrow peak shapes, and a rapid analysis time. This ingredient screen can easily be used as a starting point for individual formulations as well as transferred between R&D and QC instrumentation due to the direct scalability of all three Kinetex EVO C18 particle sizes (1.7 μm, 2.6 μm, 5 μm).

Read the full article now

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Receive content, products, events as well as relevant industry updates from The Analytical Scientist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine